What's breaking now, across thousands of outlets.
Some four months after the White House inked the last of its expected drug pricing deals with 17 of the industry’s top players, the U.S. government is back for round 2, this time lining up agreements with a host of medium-sized biopharmas under President Trump’s ‘most favored nation’ agenda.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.
Nine new companies have announced voluntary drug pricing deals with the White House, looking to avoid industry tariffs and inclusion in two CMS pilot programs under review that are thought to be…
The world champion will remain in hospital for several days following the operation, UAE Team Emirates-XRG announced
India seeks predictable regulatory pathways in Brazil to boost pharmaceutical exports. This move aims to ensure affordable and quality medicines for accessible healthcare.
“There has been a wealth of new treatment available” for migraine prevention, said a co-author of new guidelines released Monday.
An incredible medicine we still don’t fully understand. Don't miss a story, subscribe here.
New research reveals that living in a democracy is linked to better mental health, primarily because it fulfills a basic psychological need for autonomy.
